{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:24:28Z","timestamp":1774484668847,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1657,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.jacc.2008.08.071","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T09:39:02Z","timestamp":1230716342000},"page":"24-29","source":"Crossref","is-referenced-by-count":82,"title":["Prevention of Recurrent Lone Atrial Fibrillation by the Angiotensin-II Converting Enzyme Inhibitor Ramipril in Normotensive Patients"],"prefix":"10.1016","volume":"53","author":[{"given":"Fabio","family":"Belluzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sernesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Preti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Salinaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luisa","family":"Fonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Perlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.jacc.2008.08.071_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/hrt.76.3_Suppl_3.79","article-title":"ACE inhibitors and arrhythmias","volume":"76","author":"Campbell","year":"1996","journal-title":"Heart"},{"issue":"Suppl","key":"10.1016\/j.jacc.2008.08.071_bib2","first-page":"VI49","article-title":"Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure","volume":"87","author":"Fletcher","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.08.071_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.CIR.100.4.376","article-title":"Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction","volume":"100","author":"Pedersen","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.08.071_bib4","first-page":"1A","article-title":"Consensus recommendations for the management of chronic heart failure","volume":"83","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2008.08.071_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.fjc.0000193808.99773.28","article-title":"Losartan and prevention of atrial fibrillation recurrence in hypertensive patients","volume":"47","author":"Fogari","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2008.08.071_bib6","first-page":"152","article-title":"Pharmacological cardioversion and prophylaxis of relapsing non valvular fibrillation (FANV) in patients with arterial hypertension (abstr)","volume":"2","author":"Belluzzi","year":"2000","journal-title":"Mediterranean J Pacing Electrophysiol"},{"key":"10.1016\/j.jacc.2008.08.071_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.08.071_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2004.03.056","article-title":"Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation","volume":"44","author":"L'Allier","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.08.071_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/clc.4960280609","article-title":"The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients: a randomized clinical study","volume":"28","author":"Celik","year":"2005","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2008.08.071_bib10","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.08.071_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/hrt.16.2.189","article-title":"Lone auricular fibrillation","volume":"16","author":"Evans","year":"1954","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2008.08.071_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3317\/jraas.2004.027","article-title":"Prevention of recurrences in patients with lone atrial fibrillation","volume":"5","author":"Madrid","year":"2004","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jacc.2008.08.071_bib13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2008.08.071_bib14","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"19","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.08.071_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.08.071_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2008.08.071_bib17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2008.08.071_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","volume":"48","author":"Fuster","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.08.071_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM198709103171104","article-title":"The natural history of lone atrial fibrillation","volume":"317","author":"Kopecky","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.08.071_bib20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0002-8703(99)70209-7","article-title":"Lone atrial fibrillation: epidemiology and natural history","volume":"137","author":"Gersh","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.08.071_bib21","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archinte.159.10.1118","article-title":"Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk","volume":"159","author":"Kopecky","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2008.08.071_bib22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0002-8703(99)70224-3","article-title":"Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up","volume":"137","author":"Scardi","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2008.08.071_bib23","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/CIRCULATIONAHA.106.644484","article-title":"Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study","volume":"115","author":"Jahangir","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.08.071_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10840-005-2360-0","article-title":"Latent arterial hypertension in apparently lone atrial fibrillation","volume":"13","author":"Katritsis","year":"2005","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2008.08.071_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0002-9149(99)80240-9","article-title":"Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episode","volume":"76","author":"Rostagno","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2008.08.071_bib26","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/eurheartj\/ehi483","article-title":"Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up","volume":"26","author":"Osranek","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2008.08.071_bib27","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1161\/01.CIR.0000072793.81076.D4","article-title":"Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.08.071_bib28","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2008.08.071_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2008.08.071_bib30","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","article-title":"Histological substrate of atrial biopsies in patients with lone atrial fibrillation","volume":"96","author":"Frustaci","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.08.071_bib31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1378\/chest.127.2.424","article-title":"The pathology of lone atrial fibrillation","volume":"127","author":"Engel","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2008.08.071_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.bjp.0706445","article-title":"Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins","volume":"147","author":"Chen","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacc.2008.08.071_bib33","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/01.CIR.101.22.2612","article-title":"Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation","volume":"101","author":"Nakashima","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.08.071_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00439-005-0034-8","article-title":"Familial aggregation in lone atrial fibrillation","volume":"118","author":"Ellinor","year":"2005","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacc.2008.08.071_bib35","first-page":"1205","article-title":"MinK gene polymorphism in the pathogenesis of lone atrial fibrillation","volume":"64","author":"Prystupa","year":"2006","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jacc.2008.08.071_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.clpt.6100016","article-title":"A common polymorphism in SCN5A is associated with lone atrial fibrillation","volume":"81","author":"Chen","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2008.08.071_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijcard.2006.08.079","article-title":"Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility","volume":"120","author":"Fatini","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2008.08.071_bib38","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.CIR.88.4.1602","article-title":"Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure","volume":"88","author":"Gottlieb","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.08.071_bib39","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1006\/jmcc.1997.0458","article-title":"Angiotensin II receptor type 1 mRNA is upregulated in atria of patients with end-stage heart failure","volume":"29","author":"Kaprielian","year":"1997","journal-title":"J Mol Cell Cardiol"},{"issue":"Suppl 11","key":"10.1016\/j.jacc.2008.08.071_bib40","first-page":"S23","article-title":"Localization of angiotensin AT1 and AT2 receptors","volume":"10","author":"Allen","year":"1999","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109708034621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109708034621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T08:24:36Z","timestamp":1545553476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109708034621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0735109708034621"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2008.08.071","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}